Meeder Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-338
Closed -$48K 1979
2018
Q4
$48K Buy
338
+216
+177% +$32.8K ﹤0.01% 829
2018
Q3
$20K Sell
122
-1,094
-90% -$184K ﹤0.01% 1036
2018
Q2
$211K Buy
+1,216
New +$183K 0.02% 504
2017
Q4
Sell
-42
Closed -$4K 1883
2017
Q3
$4K Sell
42
-25
-37% -$1.94K ﹤0.01% 1351
2017
Q2
$5K Hold
67
﹤0.01% 1228
2017
Q1
$3K Hold
67
﹤0.01% 1323
2016
Q4
$2K Buy
+67
New +$1.72K ﹤0.01% 947

Other funds holding LOXO

Meeder Asset Management's LOXO Position: Q1 2019 in Review

Meeder Asset Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 338 shares — an estimated $48K sold.

Meeder Asset Management first reported a position in LOXO in Q4 2016 and held it in 7 quarters. The position peaked at $211K in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Meeder Asset Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Meeder Asset Management sold 338 Loxo Oncology, Inc shares in Q1 2019, an estimated $48K.
  • Meeder Asset Management first reported a position in Loxo Oncology, Inc in Q4 2016 and held it in 7 quarters.
  • Meeder Asset Management's Loxo Oncology, Inc position peaked at $211K in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Meeder Asset Management's 13F filing for Q1 2019, filed 16 Apr 2019.